Cleared Traditional

K231779 - REMI AI Discrete Detection Module (FDA 510(k) Clearance)

Jan 2024
Decision
201d
Days
Class 2
Risk

K231779 is an FDA 510(k) clearance for the REMI AI Discrete Detection Module. This device is classified as a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II - Special Controls, product code OMB).

Submitted by Epitel, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on January 3, 2024, 201 days after receiving the submission on June 16, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User.

Submission Details

510(k) Number K231779 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 2023
Decision Date January 03, 2024
Days to Decision 201 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMB - Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User